\begin{table}[htbp]
\centering
\caption{Robustness Checks: Alternative Comparisons and Heterogeneity}
\label{tab:robust}
\begin{tabular}{l cccc}
\toprule
& (1) & (2) & (3) & (4) \\
& Phase I & Dose- & High & Low \\
& vs II & Response & Baseline & Baseline \\
\midrule
\multicolumn{5}{l}{\textit{Panel A: Non-Farm Worker Share}} \\
Estimate & 0.0059 & -0.0018 & 0.0603* & 0.0189 \\
& (0.0070) & (0.0032) & (0.0329) & (0.0140) \\
\midrule
RI $p$-value & --- & --- & --- & --- \\
Main estimate RI $p$ & \multicolumn{4}{c}{0.032 (500 permutations)} \\
\bottomrule
\end{tabular}
\begin{minipage}{0.95\textwidth}
\vspace{0.2cm}
\footnotesize \textit{Notes:} Column 1: Phase I vs Phase II districts (both early treated). Column 2: dose-response regression of $\Delta$ non-farm share (2001--2011) on years of MGNREGA exposure by 2011, with state FE. Columns 3--4: Phase I vs Phase III, split by median baseline non-farm share in 2001. RI $p$-value from 500 random permutations of phase assignment. * $p<0.10$, ** $p<0.05$, *** $p<0.01$.
\end{minipage}
\end{table}
